Literature DB >> 9393773

Interleukin-12 is critical for induction of nitric oxide-mediated immunosuppression following vaccination of mice with attenuated Salmonella typhimurium.

M G Schwacha1, T K Eisenstein.   

Abstract

Studies from our laboratory have shown that infection of mice with an attenuated strain of Salmonella typhimurium causes a marked suppression in the capacity of splenocytes to generate an in vitro plaque-forming cell (PFC) response to sheep erythrocytes. The suppression has been shown to be mediated by mature, adherent macrophages (Mphis) and nonadherent, precursor Mphis. Nitric oxide has been identified as the suppressor factor. The present study investigated the role of interleukin-12 (IL-12) in the generation of nitric oxide-mediated immunosuppression in this model. Salmonella inoculation resulted in marked suppression of PFC responses and high levels of nitrite production. When mice were treated with anti-IL-12 prior to inoculation, nitrite levels in splenocyte cultures were reduced by 75% and the suppression of PFC responses was prevented. The nonadherent splenocyte fraction from Salmonella-inoculated mice, which contains precursor Mphis and is weakly immunosuppressive, was treated with IL-12 in vitro. IL-12 augmented the capacity of this fraction to suppress PFC responses by normal splenocytes in a coculture system. Additionally, IL-12 induced nitrite and gamma interferon (IFN-gamma) production in a dose-dependent manner. Treatment with anti-IFN-gamma blocked nitrite production and suppression, indicating that IFN-gamma is an important intermediary in the pathway of IL-12-induced immunosuppression. These results indicate that IL-12 is critical for the induction of nitric oxide-mediated immunosuppression following S. typhimurium inoculation and, through its ability to stimulate IFN-gamma production, can induce nitric oxide-producing suppressor Mphis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9393773      PMCID: PMC175706          DOI: 10.1128/iai.65.12.4897-4903.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  74 in total

Review 1.  Suppressor macrophages.

Authors:  T K Eisenstein
Journal:  Immunol Ser       Date:  1994

2.  The adjuvant effect of interleukin-12 in a vaccine against Leishmania major.

Authors:  L C Afonso; T M Scharton; L Q Vieira; M Wysocka; G Trinchieri; P Scott
Journal:  Science       Date:  1994-01-14       Impact factor: 47.728

3.  Interleukin 12 in host defense against microbial pathogens.

Authors:  R M Locksley
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

4.  Interleukin 12 primes macrophages for nitric oxide production in vivo and restores depressed nitric oxide production by macrophages from tumor-bearing mice: implications for the antitumor activity of interleukin 12 and/or interleukin 2.

Authors:  J M Wigginton; D B Kuhns; T C Back; M J Brunda; R H Wiltrout; G W Cox
Journal:  Cancer Res       Date:  1996-03-01       Impact factor: 12.701

5.  Role of gamma interferon in late stages of murine salmonellosis.

Authors:  A Muotiala; P H Mäkelä
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

6.  Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist.

Authors:  C S Tripp; S F Wolf; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

7.  Endogenous and exogenous interleukin-12 augment the protective immune response in mice orally challenged with Salmonella dublin.

Authors:  T Kincy-Cain; J D Clements; K L Bost
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

Review 8.  Interleukin-12.

Authors:  M J Brunda
Journal:  J Leukoc Biol       Date:  1994-02       Impact factor: 4.962

Review 9.  Immunoregulation by interleukin-12.

Authors:  G Trinchieri; F Gerosa
Journal:  J Leukoc Biol       Date:  1996-04       Impact factor: 4.962

10.  IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expression.

Authors:  J B Rao; R S Chamberlain; V Bronte; M W Carroll; K R Irvine; B Moss; S A Rosenberg; N P Restifo
Journal:  J Immunol       Date:  1996-05-01       Impact factor: 5.422

View more
  12 in total

1.  The quantity of nitric oxide released by macrophages regulates Chlamydia-induced disease.

Authors:  Jin Huang; Fred J DeGraves; Stephen D Lenz; Dongya Gao; Pu Feng; Dan Li; Tobias Schlapp; Bernhard Kaltenboeck
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

2.  Nitric oxide-mediated immunosuppression following murine Echinococcus multilocularis infection.

Authors:  W J Dai; B Gottstein
Journal:  Immunology       Date:  1999-05       Impact factor: 7.397

3.  Role of gamma interferon in cellular immune response against murine Encephalitozoon cuniculi infection.

Authors:  I A Khan; M Moretto
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

4.  Salmonella typhimurium infection in mice induces nitric oxide-mediated immunosuppression through a natural killer cell-dependent pathway.

Authors:  M G Schwacha; J J Meissler; T K Eisenstein
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

5.  Dose-dependent lymphocyte apoptosis following respiratory infection with Vaccinia virus.

Authors:  Nicole L Yates; Rama D Yammani; Martha A Alexander-Miller
Journal:  Virus Res       Date:  2008-08-23       Impact factor: 3.303

6.  High dose interleukin-12 exacerbates Bordetella pertussis infection and is associated with suppression of cell-mediated immunity in a murine aerosol challenge model.

Authors:  C R D Carter; B M Dagg; K M Whitmore; J R Keeble; C Asokanathan; D Xing; K B Walker
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

7.  In vivo-selected mutations in methyl-directed mismatch repair suppress the virulence attenuation of Salmonella dam mutant strains following intraperitoneal, but not oral, infection of naïve mice.

Authors:  Douglas M Heithoff; Golnaz Badie; Steven M Julio; Elena Y Enioutina; Raymond A Daynes; Robert L Sinsheimer; Michael J Mahan
Journal:  J Bacteriol       Date:  2007-04-27       Impact factor: 3.490

8.  Macrophage migration inhibitory factor (MIF) plays a pivotal role in immunity against Salmonella typhimurium.

Authors:  Heidrun Koebernick; Leander Grode; John R David; Wolfgang Rohde; Michael S Rolph; Hans-Willi Mittrücker; Stefan H E Kaufmann
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-23       Impact factor: 11.205

9.  In vivo blockage of nitric oxide with aminoguanidine inhibits immunosuppression induced by an attenuated strain of Salmonella typhimurium, potentiates Salmonella infection, and inhibits macrophage and polymorphonuclear leukocyte influx into the spleen.

Authors:  A S MacFarlane; M G Schwacha; T K Eisenstein
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

10.  Interleukin-12 is required for control of the growth of attenuated aromatic-compound-dependent salmonellae in BALB/c mice: role of gamma interferon and macrophage activation.

Authors:  P Mastroeni; J A Harrison; J H Robinson; S Clare; S Khan; D J Maskell; G Dougan; C E Hormaeche
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.